tag tanezumab 
pharmaphorum
DECEMBER 2, 2020
Likewise, tanezumab, an anti-osteoarthritic, failed in trials. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. The news of this disastrous result came days after CEO Jeff Kindler had hailed the drug as potentially “one of the most important compounds of our generation”.
The Pharma Data
MAY 4, 2021
There was a single voting question focused on whether the proposed risk evaluation and mitigation strategy (REMS) for tanezumab will ensure its benefits outweigh its risks, and the Committee voted 1 in favor and 19 against. Somatrogon — In February 2021, Pfizer and OPKO Health Inc. A decision from the EC is expected in 2022.
Expert insights. Personalized for you.
128 
Let's personalize your content